Epilepsy Research Foundation
A partnership among three leading non-profit epilepsy organizations:
Epilepsy Foundation, Epilepsy Therapy Project and Finding a Cure for Epilepsy and Seizures (f.a.c.e.s)
New Therapy Research
This is a pivotal time for epilepsy research. Our understanding of epilepsy has never been greater. In an environment of remarkable advances, innovative discoveries and new approaches to diagnosis, treatment and prevention, the time to intensify our search for a cure is now. Recent advances in technology and the decoding of the human genome have opened the door to new avenues of research. Research in genetics, new drug development, surgery and technology hold the key to controlling and preventing seizures. We have never been so close.
Looking back on the progress in the last generation, it is not surprising that the leaders in epilepsy research believe that a cure may be in sight. For the first time, we can think in terms of “cure”—not just “control”. Now is the time to build on the remarkable progress of the past few years. And we can do it by investing more money in scientific research than we ever have before.
The mission of Epilepsy Research Foundation is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. The Foundation funds innovative senior level research projects led by the nation’s leading scientists with the potential to discover new treatment options and ultimately a cure.
The Epilepsy Research Foundation focuses on:
- Research with potential to discover new therapies and a cure for seizure disorders.
- Meaningful grants to senior level scientific and clinical investigators on the brink of new discoveries, working at the nation’s leading academic and research institutions, and in industry.
- Innovative cutting edge projects that could lead to breakthrough discoveries.
- Research programs that might not otherwise be funded through traditional sources.
- Projects that encourage collaboration among scientists and industry.